| Prev Close | 586.88 |
| Open | 588.83 |
| Day Low/High | 583.76 / 595.48 |
| 52 Wk Low/High | 328.12 / 664.64 |
| Volume | 626.46K |
Regeneron Pharmaceuticals, Inc. (REGN)
586.06
0.82
0.14
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 106.54B |
| Market Cap | 62.19B |
| P/E Ratio | 19.71 |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: I Warned You That Betting Against Science Is a Mug's Game
And I was right, and the cynics were wrong. Here's why that matters more than ever now.
Following Up on Our Regeneron Recommendation
Here's what traders should consider doing now.
ARKK Under Pressure, Peloton, Vaccine Moral Dilemma, Charting the Nasdaq
The fund is at a key spot technically, and there is real fear that if this spot cracks, what looks like a stretch of rough rapids could become a waterfall.
Jim Cramer: Don't Bet Against Comebacks in This Second Chance Market
Just like you have to know how to read a room, you have to know how to read a tape and this tape screams 'I'm not done yet.'
Jim Cramer: We've Got a Boom ... and a Bust
Let's look at this impossible move on the market -- and why health care could be coming off life support.
Here's How I'd Treat Regeneron
It looks like it's time to go long Regeneron, as the charts have improved.
There's No Rush to Purchase Regeneron Stock
The charts are not particularly attractive at this point in time.
Jim Cramer: It's Time for Clear COVID Rules That Make Sense
Outside of the pro sports world, it seems like amateur hour with regard to protocols.
Jim Cramer: Here Are the Biden Stocks
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
Jim Cramer: If Government Gets Its Act Together, This Is What Could Happen
The vaccine rollout has been bungled and the nation's in crisis, but you can either dwell on the negativity or look to ingenuity and opportunity. Here's where I see the latter.
How to Play Emergent BioSolutions Right Now
A correction in EBS could soon set up an attractive opportunity.
Looking at 4 Potential Buy Setups This Week
Let's review the charts of DBX, FSLY, REGN, and SPCE.
The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events
This Friday several banks begin the unofficial kickoff of 'earnings season'.
Covid Vaccine Distribution, Jobs, Stimulus Package, Brexit Terms, Investor Days
Most important come Inauguration Day is the seamless transition of leadership over 'Operation Warp Speed'.
November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
Broadening Market Performance, the Vaccine 'Put', Trading McKesson
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
Jim Cramer: This Is All Playing Out Like a Stephen King Novel
What happens when everyone hunkers down, creating their own de facto stay-in-place lockdown?
Earnings News Will Provide a Respite From Covid and Election Uncertainty
There is little reason to anticipate a sustained bounce at this point, but there are positive aspects to the price action.
Sorrento Therapeutics Stock Is Not That Attractive Now
I like to look for more compelling setups.
Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
Jim Cramer: Here's How We're Going to Beat Covid-19
Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.
Jim Cramer: Here's Why the President Is Gambling With Stimulus
The market is reflecting a triumph of big business over small business, and here's what that means for individual stocks.
Jim Cramer: The President's Behavior Towards Covid-19
I know that Trump's going to blunt our community mask initiative because who needs masks if it isn't a big deal if you are sick?
Trump's Health and the Market, Charts That Matter, Nvidia News, URI Breaks Out
Even more important than fiscal support moving forward would be the concept of Covid-19 very soon being effectively treatable for the public.
Real Money Post Industrial Average Outperforms Major Indexes in September
The RMPIA rose 13.8% during the quarter, leaving it up just shy of 29% on a year-to-date basis, thanks to performance by CRM, AAPL , NKE and TMO.
Jim Cramer: Does Everyone Out There Perceive That Everything Is a Win?
It's remarkable to see such excitement based on totally contradictory theories and themes.
